Sana Biotechnology (NASDAQ:SANA) Hits New 52-Week Low After Analyst Downgrade

Sana Biotechnology, Inc. (NASDAQ:SANA – Get Free Report) hit a new 52-week low on Tuesday after HC Wainwright lowered their price target on the stock from $11.00 to $8.00. HC Wainwright currently has a buy rating on the stock. Sana Biotechnology traded as low as $2.85 and last traded at $3.04, with a volume of […]

Leave a Reply

Your email address will not be published.

Previous post Austin Private Wealth LLC Buys 67 Shares of Union Pacific Co. (NYSE:UNP)
Next post Clarity Capital Partners LLC Purchases 194 Shares of General Electric (NYSE:GE)